课题基金 / 基金详情

Mechanism for ischemic crosstoleance in central nervous system and its therapeutic application

Mechanism for ischemic crosstoleance in central nervous system and its therapeutic application
中枢神经系统缺血交叉耐受机制及其治疗应用
批准号:
17390429
负责人:
SAKABE Takefumi
金额:
$10.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

SAKABE Takefumi的其他基金

相似基金

相关文献

中文摘要
翻译
我们先前已经证明,在缺血前重复高压氧(HBO)暴露(3.5绝对大气压(ATA))可显著减少短暂性前脑缺血后海马区CA1神经元的丢失。1)不同压力水平高压氧的作用;2)神经保护机制(用基因芯片技术);3)生物学验证(用蛋白质合成抑制剂)。大鼠在100%氧气暴露(100%02组)和高压氧(分别为2ATA或3.5 MA,HBO-2ATA组,-3.5ATA组)或假手术组(Sham组)后12小时复制大鼠前脑缺血模型(8min)。3.5ATA-HBO对缺血损伤的海马神经元(存活神经元:68%)有最大的保护作用(假手术组:2.7%,100%02组:13.5%,2ATA-HBO组:44%)。基因芯片数据显示p75;lt;NTR>,C/EBPδ,CD74的表达显著上调,其时程表达与高压氧诱导的神经保护相一致。蛋白质水平是…更多的LSO显著增加(分别为2.9、2.0和7.9)。此外,我们还观察了在高压氧暴露前给予蛋白质合成抑制剂山奈素(AM)或放线菌酮(CY)对神经保护的调节作用,这两种药物均可抑制高压氧诱导的神经保护作用,在给予AM和CY的大鼠中,神经元存活率分别为2.1%和8.9%。在每次AM-HBO治疗前给予p38 MAP激酶抑制剂SB203580(SB),可恢复HBO诱导的神经保护作用。相比之下,在每次CY-HBO治疗前给予SB,HBO诱导的神经保护作用仅是边缘的。由于已知AM而不是CY具有p38丝裂原激活蛋白(P38MAP)激酶的激活特性,我们的结果提示高压氧诱导的神经保护机制参与了p38 MAP激酶的抑制。综上所述,高压氧诱导的神经保护作用是通过与神经营养素和炎症免疫系统相关的从头合成蛋白的合成以及对p38 MAP激酶的抑制来实现的。较少
英文摘要
We have previously demonstrated that repeated hyperbaric oxygen (HBO) exposure (3.5 absolute atmosphere (ATA)) prior to ischemia significantly reduced loss of hippocampal CAl neurons after transient forebrain ischemia. The present study examined 1) the effects of different pressure level of HBO, 2) neuroprotective mechanism (by using microarray technology), and 3) biological verification (by using protein synthesis inhibitor).Rats were subjected to forebrain ischemia (8 min)at 12 hours after five sessions of 100% oxygen exposure (100% 02 group) and HBO (at 2 ATA or 3.5 MA, (HBO-2ATA, -3.5ATA group, respectively)) or sham treatment (sham group). 3.5ATA-HBO maximally protected hippocampal CAl neurons (survived neurons : 68%) against ischemic damage(sham group : 2.7%, 100% 02 group : 13.5%, 2 ATA-HBO group : 44%).Microarray data showed significant up-regulation in p75^<NTR>, C/EBP δ, CD74, whose time-course expressions corresponded to HBO-induced neuroprotection. The protein levels were a … More lso significantly increased (2.9, 2.0, and 7.9, respectively). Further, we examined the modulation of neuroprotection by administering protein synthesis inhibitor, anisomycin (AM) or cycloheximide (CY) prior to HBO exposure, both of which inhibited HBO-induced neuroprotection, survived neuron being 2.1 and 8.9% in the rats treated with AM and CY, respectively. With administration of p38 MAP kinase inhibitor, SB203580 (SB), before each treatment with AM-HBO, HBO-induced neuroprotection was resumed. In contrast, with administration of SB before each treatment with CY-HBO, HBO-induced neuroprotection was only marginal. Because AM, but not CY, has been known to have activating property of p38 mitogen-activated protein (p38MAP) kinase, our results suggest that the mechanism of HBO-induced neuroprotection is involved in suppression of p38 MAP kinase.In conclusion, HBO induced neuroprotection against the neuronal damage in the hippocampal CAl following forebrain ischemia is mediated by de novo protein synthesis relevant to neurotrophin and inflammatory-immune system and to suppression of p38 MAP kinase. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.brainres.2006.10.077
发表时间: 2007-01-26
期刊: BRAIN RESEARCH
影响因子: 2.9
作者: [Hirata, Takao, Cui, Ying Jun, Sakabe, Takefumi]
通讯作者: Sakabe, Takefumi
Ischemic tolerance induced by repeated hyperbaric oxygen In rat brain:Time window and genome-wide gene and protein expression
重复高压氧诱导大鼠脑缺血耐受:时间窗和全基因组基因和蛋白表达
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Takao Hirata, et. al.]
通讯作者: et. al.
中枢神経における虚血耐性
中枢神经系统的缺血耐受性
DOI: --
发表时间: 2005
期刊: 蘇生 24
影响因子: --
作者: [松本 美志也, 他, Takao Hirata, 山下 敦, 松本 美志也]
通讯作者: 松本 美志也
Ischemic preconditioning in the central nervous system
中枢神经系统缺血预处理
DOI: --
发表时间: 2005
期刊: Japanese Journal of Reanimatology 24
影响因子: --
作者: [Mishiya, Matsumoto, Kazuhiko, Nakakimura, Mitsuyoshi, Yoshida, Takao, Hirata, Takefumi, Sakabe]
通讯作者: Sakabe
共 11 条
    Investigation on therapeutic potentials of inducing ischemic tolerance against ischemic neuronal damage in the spinal cord
    • 批准号:
      14370490
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2002
    • 负责人:
      SAKABE Takefumi
    • 依托单位:
    The machanism of delayed motor neuron death after transient spinal cord ischemia
    • 批准号:
      11470323
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.41万
    • 财政年份:
      1999
    • 负责人:
      SAKABE Takefumi
    • 依托单位:
    The pathogenesis and treatment of cerebral ischemia based on the mechanism of cytoskeletal changes
    • 批准号:
      07457357
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.26万
    • 财政年份:
      1995
    • 负责人:
      SAKABE Takefumi
    • 依托单位:
    Experimental studies of pathophysiology and treatment of spinal cord ischemia
    • 批准号:
      05454423
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.67万
    • 财政年份:
      1993
    • 负责人:
      SAKABE Takefumi
    • 依托单位:
    海外基金